These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17641999)

  • 21. How will biotechnology fare in pharma's big plan?
    Nat Biotechnol; 1996 Nov; 14(11):1515. PubMed ID: 9634811
    [No Abstract]   [Full Text] [Related]  

  • 22. Overcoming further challenges in the pharma/biotech industry: 2007 update.
    Graul AI; Cruces E; Revel L; Serradell N; Rosa E
    Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Geron-Roslin alliance aims broadly at degenerative diseases.
    Fox JL
    Nat Biotechnol; 1999 Jun; 17(6):529-30. PubMed ID: 10385308
    [No Abstract]   [Full Text] [Related]  

  • 24. Merck moves into biotech.
    Kling J
    Nat Biotechnol; 2006 Jul; 24(7):730. PubMed ID: 16841041
    [No Abstract]   [Full Text] [Related]  

  • 25. What's fueling the biotech engine?
    Aggarwal S
    Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
    [No Abstract]   [Full Text] [Related]  

  • 26. Mike Varney.
    Varney M; Mullard A
    Nat Rev Drug Discov; 2015 Mar; 14(3):158-9. PubMed ID: 25677359
    [No Abstract]   [Full Text] [Related]  

  • 27. R&D deals boom in 2004.
    Lawrence S
    Nat Biotechnol; 2005 Sep; 23(9):1036. PubMed ID: 16151383
    [No Abstract]   [Full Text] [Related]  

  • 28. Biotechnology in Ireland: hard work, money and the brain gain.
    O'Neill MF
    Drug Discov Today; 2007 Feb; 12(3-4):108-11. PubMed ID: 17275730
    [No Abstract]   [Full Text] [Related]  

  • 29. Lino Barañao interview. New minister raises expectations for science in Argentina. Interview by Jocelyn Kaiser and Eliot Marshall.
    Barañao L
    Science; 2008 Aug; 321(5889):622. PubMed ID: 18669827
    [No Abstract]   [Full Text] [Related]  

  • 30. The production capacity bottleneck.
    De Keyser JL
    Nat Biotechnol; 2001 Aug; 19(8):715. PubMed ID: 11479555
    [No Abstract]   [Full Text] [Related]  

  • 31. Merck's recall of rofecoxib--a strategic perspective.
    Oberholzer-Gee F; Inamdar SN
    N Engl J Med; 2004 Nov; 351(21):2147-9. PubMed ID: 15548771
    [No Abstract]   [Full Text] [Related]  

  • 32. Biotech at the beauty counter.
    Nasto B
    Nat Biotechnol; 2007 Jun; 25(6):617-9. PubMed ID: 17557090
    [No Abstract]   [Full Text] [Related]  

  • 33. Genentech faces the consequences of growth.
    Ransom J
    Nat Biotechnol; 2007 Apr; 25(4):371. PubMed ID: 17420731
    [No Abstract]   [Full Text] [Related]  

  • 34. Early-stage returns?
    Booth BL
    Nat Biotechnol; 2006 Nov; 24(11):1335-40. PubMed ID: 17093473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novartis' role in 21st century drug development.
    Vasella D
    Nat Biotechnol; 1997 Jun; 15(6):485. PubMed ID: 9181555
    [No Abstract]   [Full Text] [Related]  

  • 36. Designs that enrich lives.
    Link A; Stark H
    Arch Pharm (Weinheim); 2007 Oct; 340(10):509-10. PubMed ID: 17912676
    [No Abstract]   [Full Text] [Related]  

  • 37. AchemAsia 2007 announcement: China's biotechnology industry on the upswing.
    Biotechnol J; 2007 Mar; 2(3):288-90. PubMed ID: 17354215
    [No Abstract]   [Full Text] [Related]  

  • 38. Deal watch: Trends in platform technology deal-making.
    Walker J; Jacob J
    Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
    [No Abstract]   [Full Text] [Related]  

  • 39. Profiles of four top biotech companies in India.
    Suresh N; Rao ChS
    Biotechnol J; 2009 Mar; 4(3):295-300. PubMed ID: 19296435
    [No Abstract]   [Full Text] [Related]  

  • 40. Gaining medical momentum.
    Blake D
    Nature; 2004 Jun; 429(6991 Suppl):19-23. PubMed ID: 15175707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.